News

Amalgamated Bank Achieves Record Stock Price Amid Growth

Amalgamated Bank Achieves Record Stock Price Amid Growth

Amalgamated Bank's Stock Surges to New Heights

Amalgamated Bank (NASDAQ: AMAL) has made headlines with its stock price soaring to an impressive $33.34, marking an all-time high. This achievement highlights the bank's strong performance and a significant increase in investor confidence. Over the past year, the stock's value has nearly doubled, showing a remarkable change of 95.17%. This surge is a testament to the bank's robust financial results and favorable market conditions, which have attracted both individual and institutional investors.

Solid Earnings and Growth in Deposits

Recently, Amalgamated Bank reported a strong financial performance, beating earnings expectations by $0.13 per share in the latest quarter. The growth was primarily fueled by a notable increase of over 20% in political deposits, which contributed to an impressive rise of over $759 million in total deposits. These deposits predominantly came from political entities, unions, and non-profit organizations. In light of these strong results, Piper Sandler has reaffirmed its Overweight rating for Amalgamated Bank, maintaining a price target of $36.00, which reflects optimism about the bank's future performance.

Analysts Remain Optimistic

Keefe, Bruyette & Woods have also shown a positive outlook on Amalgamated Bank, revising their price target from $30.00 to $35.00 while keeping an Outperform rating. The bank's proactive strategy to manage excess deposits off its balance sheet is expected to mitigate earnings volatility leading into 2025. This strategic approach, combined with a favorable outlook for net interest income, has resulted in a 6% upward revision of EPS estimates for the years 2024 and 2025.

Future Projections for the Bank

While there are expectations of political deposits potentially declining in the third quarter, Amalgamated Bank remains hopeful about maintaining its strong momentum through the end of the year and into 2025. The bank has recalibrated its target balance sheet size for year-end to approximately $8.3 billion, sustaining interest from analysts and investors alike. This proactive adjustment reaffirms the bank's commitment to growth and stability in changing market conditions.

InvestingPro Insights on Stock Performance

Amalgamated Bank's (AMAL) remarkable stock performance is further validated by key metrics provided by InvestingPro. The shares are currently trading at 98.77% of their 52-week peak, corroborating the claim of achieving an all-time high. Moreover, an impressive total return of 88.67% over the past year aligns closely with the noted 95.17% increase, emphasizing the bank's solid financial health.

P/E Ratio and Investor Interest

The recent InvestingPro analysis indicates that AMAL's P/E ratio stands at 10.17, suggesting it may be undervalued based on its earnings. This observation is supported by an InvestingPro Tip, stating that the bank is trading at a relatively low P/E ratio when compared to its anticipated near-term earnings growth, further enhancing investor interest.

Financial Health Overview

Recent data also showcases Amalgamated Bank's sound financial health with a quarterly revenue growth rate of 12.39%, alongside a robust operating income margin of 49.44% for the last twelve months as of the recent quarter. This strong performance corroborates the previous points about the bank's successful financial strategies that have contributed to its rise.

Frequently Asked Questions

What has been the highest stock price for Amalgamated Bank?

The highest stock price reached by Amalgamated Bank is $33.34, marking a historical peak.

What factors contributed to the stock price increase?

The stock price increase was driven by strong financial performance and substantial growth in political deposits.

How did analysts respond to Amalgamated Bank's performance?

Analysts have maintained positive ratings and increased price targets, showcasing confidence in the bank's future.

Is Amalgamated Bank's stock considered undervalued?

Yes, the P/E ratio indicates that Amalgamated Bank's stock might be undervalued compared to its earnings potential.

What is the growth outlook for Amalgamated Bank?

The growth outlook remains optimistic, with adjustments to the target balance sheet and expectations for sustained performance.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Rural Hospitals Face Shaky Future; Warbird RCM Steps In

Updated Category News Views 6

Revamping Revenue Cycle Management for Rural Healthcare In a world that's increasingly teetering on the delicate tightrope of balance sheets, Warbird Healthcare Advisors is stepping into the ring with fists up, ready to fight for rural hospitals. Introducing their latest venture, Warbird RCM Partners, they're honing in on revenue cycle management and billing services to...

Continue Reading
Got Electric Expands to Coeburn, Strengthening Infrastructure

Updated Category News Views 4

You ever get tired of hearing the same old corporate spiel? Well, here's something real—Got Electric just opened a new office in Coeburn, Virginia, and it ain't just another pin on the map. It’s a move with some teeth, beefing up their ability to handle the electrical needs of Virginia, Tennessee, and North Carolina. A strategic play that’s got some serious regional...

Continue Reading
Italian Excellence: NYC Celebrates Innovators and Icons

Updated Category News Views 41

The Fusion of Italian Artistry and Innovation Imagine blending business savvy with a touch of culture and ethics. That's the spirit of the 9th Business Care International Award, which is gearing up to hit New York City's grand stage come November 18-19. This ain't just about pats on the back; it's a recognition of those who push Italian excellence across oceans and into...

Continue Reading
Duni Group Faces Ups and Downs in Q3 2026

Updated Category News Views 2

Navigating Choppy Waters: Duni's Third Quarter 2026 Alright, folks, let's dive into the latest from Duni Group—a company feeling the pinch but pushing through with some resilience. The third quarter 2026 report has just landed, and while some numbers are headed up, plenty are a bit of a gut punch. This isn't a crisis, but it's no smooth sailing either. Let's cut through...

Continue Reading
Vinitaly.USA 2026: Italian Wine Takes Manhattan

Updated Category News Views 11

A Two-Day Wine Extravaganza Hits New York If Italian wine was a stock, the Vinitaly.USA 2026 gathering in New York would be a rallying cry to double down. October 26-27 is set to be a whirl of handshakes and clinking glasses at Pier 36, all under the grand vision of beefing up Italy's hold on the U.S. wine market. As the compass points to growing opportunities, one can't...

Continue Reading
Hyperliquid Reports Q3 2026 Results with Webcast Insights

Updated Category News Views 13

Unlocking Hyperliquid’s Third Quarter Performance It's time to grab your investing gear because Hyperliquid Strategies Inc is ready to spill the beans on their Q3 2026 performance. The digital asset treasury focused on the hyperventilating HYPE token—fined-tuned to serve US and institutional investors—is broadcasting a live webcast on November 5, 2026. Mark your...

Continue Reading
Victor Care Networks Explores Transformative Mental Health

Updated Category News Views 4

Connections at the Core of Care Victor Care Network is stepping into the spotlight with a feature on "All Access hosted by Andy Garcia," putting human relationships front and center in mental health support. This ain't just another run-of-the-mill initiative—it’s a deep dive into the bonds that help people when the chips are down. So, what's it all about? Helping...

Continue Reading
Basic Invite's Holiday Card Service Offers Saving Time

Updated Category News Views 6

Getting the Cards Out: Maneuvering the Holiday Hustle Alright, let's dive into the madness that is holiday card season. Could be a logistical nightmare or a nostalgic tradition, depending on your cup of tea. Basic Invite here is trying to cut through the chaos by bumping deadlines and offering some straight-out-the-gate mailing options. If you play your cards right—pun...

Continue Reading
Gala Spotlights Veterans' Mental Health Support

Updated Category News Views 11

Champions for Veterans Honored at Headstrong Gala If you ever wondered who stands in the trenches alongside veterans facing mental health battles, this year's Headstrong Gala offered a crystal-clear answer. Held on October 16 at Pier Sixty in New York City, this shiindig wasn’t just about schmoozing over canapés. It was about celebrating the grit and guts of those...

Continue Reading
Bybit's USD1 Program Extends with 27M WLFI Reward Pot

Updated Category News Views 2

Bybit Extends USD1 Hold & Earn Program Man, when it comes to dangling a carrot, Bybit seems to know just the right length of stick to use. For those riding the crypto wave, they're reevaluating the worth of holding onto their digital coins, especially now that Bybit has renewed its USD1 Hold & Earn program. This isn't just a token gesture—it's a whopping 27 million WLFI...

Continue Reading

Top 5 Most Recently Viewed Articles

Blue Shield of California Shines in Disability Inclusion for 2025

Updated Category News Views 163

Blue Shield of California Recognized for Disability Inclusion In celebration of National Disability Employment Awareness Month, Blue Shield of California has received recognition as a "Best Place to Work for Disability Inclusion." This accolade highlights the health plan's dedication to advancing disability inclusion and fostering a workplace that supports every employee....

Continue Reading
Gilead Sciences Plans Q3 2024 Financial Results Release Soon

Updated Category News Views 158

Gilead Sciences Announces Upcoming Q3 Financial Results FOSTER CITY, Calif. -- Gilead Sciences, Inc. (Nasdaq: GILD) is excited to share that it will unveil its third quarter 2024 financial results on November 6, 2024. This release will take place after the market closes, allowing investors and stakeholders to review the company’s performance in a timely manner....

Continue Reading
Rockwell Automation Launches Cutting-Edge Research Facility

Updated Category News Views 380

Rockwell Automation Launches New Research Lab Team of researchers will help develop industrial technologies of the future Rockwell Automation, Inc. (NYSE: ROK), the world's largest company focused on industrial automation and digital transformation, is expanding its Advanced Technology division by establishing a new research laboratory. This initiative will play a crucial...

Continue Reading
Increasing Securities Litigation Risks for Public Firms in 2025

Updated Category News Views 507

Understanding the Current Landscape of Securities Litigation Risks The landscape for U.S. public companies is shifting dramatically as new reports highlight a surge in securities litigation risks. According to a recently published study by SAR, a specialized data analytics company, the frequency and severity of corporate disclosures have intensified, leading to a notable...

Continue Reading
Myrtelle Launches Production of Innovative Gene Therapy

Updated Category News Views 186

Myrtelle Inc. Begins Manufacturing Gene Therapy for Canavan Disease A groundbreaking achievement for gene therapy advancement Myrtelle Inc., a pioneering clinical-stage gene therapy company, has officially launched the manufacturing of its innovative oligotrophic recombinant adeno-associated virus (rAAV) gene therapy designed specifically for Canavan disease. This...

Continue Reading